Quantitative assessment of atypical birefringence images using scanning laser polarimetry with variable corneal compensation
Purpose
To define the clinical characteristics of atypical birefringence images and to describe a quantitative method for their identification.
Design
Prospective, comparative, clinical observational study.
Methods
Normal and glaucomatous eyes underwent complete examination, standard automated perimetry, scanning laser polarimetry with variable corneal compensation (GDx-VCC), and optical coherence tomography (OCT) of the macula, peripapillary retinal nerve fiber layer (RNFL), and optic disk. Eyes were classified into two groups: normal birefringence pattern (NBP) and atypical birefringence pattern (ABP). Clinical, functional, and structural characteristics were assessed separately. A multiple logistic regression model was used to predict eyes with ABP on the basis of a quantitative scan score generated by a support vector machine (SVM) with GDx-VCC.
Results
Sixty-five eyes of 65 patients were enrolled. ABP images were observed in 5 of 20 (25%) normal eyes and 23 of 45 (51%) glaucomatous eyes. Compared with eyes with NBP, glaucomatous eyes with ABP demonstrated significantly lower SVM scores (P < .0001, < 0.0001, 0.008, 0.03, and 0.03, respectively) and greater temporal, mean, inferior, and nasal RNFL thickness using GDx-VCC; and a weaker correlation with OCT generated RNFL thickness (R2 = .75 vs .27). ABP images were significantly correlated with older age (R2 = .16, P = .001). The SVM score was the only significant (P < .0001) predictor of ABP images and provided high discriminating power between eyes with NBP and ABP (area under the receiver operator characteristic curve = 0.98).
Conclusions
ABP images exist in a subset of normal and glaucomatous eyes, are associated with older patient age, and produce an artifactual increase in RNFL thickness using GDx-VCC. The SVM score is highly predictive of ABP images.
To access this article, please choose from the options below
Supported in part by the Maltz Family Endowment for Glaucoma Research, Cleveland, Ohio; the New York Community Trust, New York, New York; a grant from Mr. Barney Donnelley, Palm Beach, Florida; and National Institute of Health grant R01-EY08684, Bethesda, Maryland.
PII: S0002-9394(04)01265-6
doi:10.1016/j.ajo.2004.10.019
© 2005 Elsevier Inc. All rights reserved.
